• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Kytril (granisetron hydrochloride) Intravenous Injection

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – April 2011 

Summary View

 

8 Use in Special Populations

8.4 Pediatric Use

Postoperative Nausea and Vomiting

  • Safety and efficacy have not been established in pediatric patients...Due to the lack of efficacy and the QT prolongation observed in this trial...